Phase i dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors

Andrew J. Brenner, Yael C. Cohen, Eyal Breitbart, Livnat Bangio, John Sarantopoulos, Francis J. Giles, Ernest C. Borden, Dror Harats, Pierre L. Triozzi*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology